lung cancer

The Quest To Stop Cancer From Coming Back

How physicians, researchers and advocates are working towards this goal for patients
Article

In his 15 years as a lung cancer specialist, Professor Nicolas Girard, MD, PhD, of the Curie-Montsouris Thorax Institute has seen – and helped advance – dramatic changes in how patients with this disease are treated. Yet despite this progress, lung cancer remains the leading cause of cancer deaths globally, and even patients who are diagnosed early often experience recurrence.

Stand Up To Cancer® Announces New Research and Education Effort Focused on Improving Health Equity for Underserved Lung Cancer Patients

New grant from Bristol Myers Squibb will help fund projects that address gaps in access to lung cancer care in rural and Black communities
Press Release

NEW YORK, July 16, 2020 /3BL Media/ – Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities. Despite recent progress in treating lung cancer, the disease remains the leading cause of cancer death in the U.S. with particularly high death rates in rural communities and among Black men. 

An Expert Explains the Latest Good—Yes, Good!—News About Lung Cancer

By Jennifer Rainey Marquez
Summary: 

A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what's to come in better detecting and preventing it.

Article

A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what's to come in better detecting and preventing it.

Going the Extra Mile for Patients

Blog

For Darcy Doege, R.N., B.S.N., of the Levine Cancer Institute, finding cancer early in patients means hitting the road.

Darcy is the Program Coordinator for the Lung B.A.S.E.S. 4 Life Program for the Charlotte-based cancer center, which launched the first mobile lung screening unit in the U.S. in 2017. This innovative idea was built to increase the early detection of lung cancer for underserved populations across North and South Carolina, thanks to a grant from the Bristol-Myers Squibb Foundation

Johnson & Johnson Raises a Flag in Early-Stage Lung Cancer with First-Ever Contest in the Field

Article

No question about it, the lung cancer field is hot—and chock-full of new drugs and combos. But there's a dearth of treatments specifically for early-stage disease, and Johnson & Johnson is looking to crowdsourcing to bring in new ideas.

Walking Forward Receives $1.6 Million Grant for Lung Cancer Screening Research

Press Release

SIOUX FALLS, S.D., February 20, 2018 /3BL Media/ – Avera Health is pleased to announce that the Walking Forward Program, based in Rapid City, has been awarded a grant for over $1.6 million from the Bristol-Myers Squibb Foundation to increase lung cancer screening rates for high-risk smokers living in western South Dakota.

The award, which will be distributed over the course of three years (2018-2020), will fund Walking Forward’s research dedicated to increasing awareness of lung cancer prevention and access to advanced lung cancer screening technology.

Booz Allen Data Science Bowl a Finalist for SXSW Innovation Award

Blog

The 2017 Data Science Bowl (DSB), Turning Machine Intelligence Against Lung Cancer—presented by Booz Allen Hamilton and Kaggle, challenged the data science and medical communities to develop algorithms that can accurately determine when lesions in the lungs are cancerous. It has been chosen as a finalist for a prestigious SXSW Innovation Award in the category of Health, Med, & BioTech.

LUNGevity Foundation Announces Initiative to Save Lives Through Increased Adherence to Lung Cancer Screening

Collaborative program to ensure more patients benefit from early detection tool
Press Release

WASHINGTON, D.C., January 31, 2018 /3BL Media/ — LUNGevity Foundation announced the launch of Project ACTS – Increasing Adherence to CT Screening for lung cancer – a multi-stakeholder project funded by a grant from Bristol-Myers Squibb Foundation through their Bridging Cancer Care™ initiative. Project ACTS will develop and evaluate tools to promote stronger adherence to lung cancer screening protocols so that patients can fully benefit from potentially life-saving CT screening.

Serving Those Who Served

Bristol-Myers Squibb Foundation has teamed up with the U.S. Department of Veterans Affairs to help improve lung cancer survival rates for veterans
Blog
With the help of the Bristol-Myers Squibb Foundation, the U.S. Department of Veterans Affairs is hoping to wage a war on lung cancer by increasing veterans’ access to lung cancer screenings across the country.

On the Front Lines with Dr. Weaver

A Kentucky physician wages his own battle against lung cancer, one house call at a time
Article

Dr. Tony Weaver pulls out of the parking lot at St. Claire Regional Medical Center, a rural hospital in the small town of Morehead, Kentucky. He has a house call to make. Today’s appointment is 20 minutes from town, down a two-lane road with no cellphone reception.

He makes rounds of home visits every other week, seeing six or seven patients each time—a welcome change from the dozens he once rushed through on an average day at a clinic.

Pages

Subscribe to lung cancer